As of Wednesday close, The Clorox Company’s (NYSE:CLX) stock was down -$0.81, moving down -0.51 percent to $156.80. The average number of shares traded per day over the past five days has been 917,220 shares. 1 time new highs have been achieved over the past 5 days, with a -$6.11 fall in that time frame. In the last twenty days, the average volume was 1,452,520, while in the previous 50 days, it was 1,195,382.
Since last month, CLX stock rose 1.80%. Shares of the company fell to $149.73 on 07/20/23, the lowest level in the past month. A 52-week high of $178.21 was reached on 05/03/23 after having rallying from a 52-week low of $124.58. Since the beginning of this year, CLX’s stock price has risen by 11.74% or $16.47, and marked a new high 17 times. However, the stock has declined by -12.01% since its 52-week high.
CLX stock investors should be aware that The Clorox Company (CLX) stock had its last reported insider trading activity 3 days ago on Aug 14. Jacobsen Kevin B, the EVP – Chief Financial Officer of the company, disposed of 3,346 shares for $160.82 on Aug 14. It resulted in a $538,096 divestment by the insider.
Valuation Metrics
Right now, The Clorox Company (CLX) has a P/E ratio of about 131.76. The stock’s beta is 0.25. Besides these, the trailing price-to-sales (P/S) ratio of 2.62, the price-to-book (PB) ratio of 88.09, and the price-to-cash flow ratio of 20.78 may also be considered.
The latest dividend of $1.20 per share was paid out, which is 1.69% more than last year’s $1.18. On Thursday July 27 2023, a $0.02 dividend increase was announced.
Financial Health
In the three months ended June 29, The Clorox Company’s quick ratio stood at 0.60, while its current ratio was 1.00, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 11.26, and the total debt-to-equity ratio was 11.49. On the profitability front, the trailing twelve-month gross margin is 39.30% percent. In the year ended June 29, operating margins totaled 3.20%. Based on annual data, CLX earned $2.91 billion in gross profit and brought in $7.39 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 5.80%. Return on equity (ROE) for the past 12 months was 68.50%.
In The Clorox Company’s quarter-end financial report for June 29, it reported total debt of $2.48 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CLX’s revenue rose 10.8% to $1.92 billion during the quarter, while net income inched up to $2.02 billion. While analysts expected The Clorox Company to report $1.18 quarterly earnings, the actual figure was $1.67 per share, beating the consensus estimate by 41.50%. During the quarter, the company generated $346.0 million in EBITDA. The liabilities of The Clorox Company were 5.56 billion at the end of its most recent quarter ended June 29, and its total debt was $2.95 billion. The value of shareholders’ equity is $123.83 million.
Technical Picture
This quick technical analysis looks at The Clorox Company’s (CLX) price momentum. With a historical volatility rate of 10.20%, the RSI 9-day stood at 43.94% on 16 August.
With respect to its five-day moving average, the current The Clorox Company price is down by -3.75% percent or -$6.11. At present, CLX shares trade +1.33% above its 20-day simple moving average and +1.42% percent above its 100-day simple moving average. However, the stock is currently trading approximately -3.39% below its SMA50 and +9.60% above its SMA200.
Stochastic coefficient K was 40.73% and Stochastic coefficient D was 47.81%, while ATR was 3.27. Given the Stochastic reading of 32.16% for the 14-day period, the RSI (14) reading has been calculated as 47.26%. As of today, the MACD Oscillator reading stands at -2.79, while the 14-day reading stands at -0.70.
Analyst Ratings
Atlantic Equities upgraded its rating on The Clorox Company (NYSE: CLX) to a Neutral in a note to investors on August 03, 2023. The analysts firm previously had an Underweight rating on the stock.The Clorox Company (CLX) has been rated Underweight by analysts. According to 6 brokerage firms, CLX is a sell, and 7 firms recommend it is a Hold. There are 3 analysts who say the stock is underweight. A total of 1 analyst rate The Clorox Company stock as buy, with 1 recommending it as overweight.
With a median target price of $153.00, the current consensus forecast for the stock is $127.00 – $185.00. Based on these forecasts, analysts predict The Clorox Company (CLX) will achieve an average price target of $157.47.
